Pulike Biological Engineering (603566) — Cash Flow Quality Index
Pulike Biological Engineering (603566) has a Cash Flow Quality Index of 2.13x as of September 2025. Operating cash flow of CN¥87.38 Million exceeds net income of CN¥40.95 Million, indicating high earnings quality where cash backs reported profits. Explore Pulike Biological Engineering debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Pulike Biological Engineering Cash Flow Quality Index (2012–2024)
Historical Cash Flow Quality Index for Pulike Biological Engineering across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 603566 operating cash flow.
Annual Cash Flow Quality Index for Pulike Biological Engineering (2012–2024)
Year-by-year earnings quality comparison for Pulike Biological Engineering.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.90x | CN¥268.79 Million | CN¥92.81 Million | ▲ +78.7% |
| 2023 | 1.62x | CN¥282.78 Million | CN¥174.52 Million | ▲ +19.1% |
| 2022 | 1.36x | CN¥228.36 Million | CN¥167.82 Million | ▲ +56.3% |
| 2021 | 0.87x | CN¥212.53 Million | CN¥244.14 Million | ▼ -24.3% |
| 2020 | 1.15x | CN¥261.83 Million | CN¥227.74 Million | ▼ -10.4% |
| 2019 | 1.28x | CN¥140.10 Million | CN¥109.25 Million | ▲ +37.7% |
| 2018 | 0.93x | CN¥126.27 Million | CN¥135.61 Million | ▼ -24.5% |
| 2017 | 1.23x | CN¥140.86 Million | CN¥114.19 Million | ▼ -8.3% |
| 2016 | 1.35x | CN¥253.03 Million | CN¥188.00 Million | ▲ +2.0% |
| 2015 | 1.32x | CN¥187.09 Million | CN¥141.74 Million | ▲ +22.4% |
| 2014 | 1.08x | CN¥151.21 Million | CN¥140.26 Million | ▼ -3.1% |
| 2013 | 1.11x | CN¥181.21 Million | CN¥162.86 Million | ▼ -2.8% |
| 2012 | 1.15x | CN¥147.96 Million | CN¥129.21 Million | — |